# Observational Study to Assess the Reliability and Validity of the MLYMT and MLSDT

> **NCT05820100** · — · COMPLETED · sponsor: **Nanoscope Therapeutics Inc.** · enrollment: 35 (actual)

## Conditions studied

- Retinitis Pigmentosa
- Retinal Dystrophy

## Interventions

- **OTHER:** Observational

## Key facts

- **NCT ID:** NCT05820100
- **Lead sponsor:** Nanoscope Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-25
- **Primary completion:** 2023-10-17
- **Final completion:** 2023-10-17
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2024-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05820100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05820100, "Observational Study to Assess the Reliability and Validity of the MLYMT and MLSDT". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05820100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*